The Enterprise Value as of December 2025 (TTM) for Lexaria Bioscience Corp. (LEXX) is 15.80M

According to Lexaria Bioscience Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.80M. This represents a change of -39.96% compared to the average of 26.31M of the last 4 quarters.

Lexaria Bioscience Corp. (LEXX) Historical Enterprise Value (quarterly & annually)

How has LEXX Enterprise Value performed in the past?

The mean historical Enterprise Value of Lexaria Bioscience Corp. over the last ten years is 12.49M. The current 15.80M Enterprise Value has changed 12.55% with respect to the historical average. Over the past ten years (40 quarters), LEXX's Enterprise Value was at its highest in in the May 2024 quarter at 45.58M. The Enterprise Value was at its lowest in in the May 2023 quarter at 1.80M.

Lexaria Bioscience Corp. (LEXX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lexaria Bioscience Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lexaria Bioscience Corp. (LEXX) Average Enterprise Value

How has LEXX Enterprise Value performed in the past?

The current Enterprise Value of Lexaria Bioscience Corp. (LEXX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Lexaria Bioscience Corp. (LEXX) Enterprise Value vs. Peers

How is LEXX’s Enterprise Value compared to its peers?

Lexaria Bioscience Corp.’s Enterprise Value is greater than Hoth Therapeutics, Inc. (6.79M), greater than Allarity Therapeutics, Inc. (-47067.00), less than Lixte Biotechnology Holdings, Inc. (18.45M), greater than Entero Therapeutics, Inc. (9.37M), greater than Clearside Biomedical, Inc. (-3870682.00), greater than Cingulate Inc. (-4702578210.00), greater than BriaCell Therapeutics Corp. (10.69M), less than CASI Pharmaceuticals, Inc. (29.33M), greater than Processa Pharmaceuticals, Inc. (8.45M), greater than Curis, Inc. (10.37M),

Build a custom stock screener for Lexaria Bioscience Corp. (LEXX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lexaria Bioscience Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lexaria Bioscience Corp. (LEXX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lexaria Bioscience Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.